The Epidemiology and Clinical Presentation of the Acute Imbalance Syndrome (AIS)-A Systematic Review and Meta-Analysis
Abstract
Objectives: The acute imbalance syndrome (AIS) refers to acute-onset and persistent vertigo, dizziness and/or imbalance without nystagmus, reflecting a subset of the acute vestibular syndrome (AVS) with or without nystagmus. While AVS with nystagmus is well characterized and the approach to these patients is validated, much less is known about patients presenting with AIS. This systematic review synthesizes current epidemiologic and clinical evidence on AIS.
Methods: MEDLINE and Embase (2000-2024) were searched for English-language original articles addressing acute imbalance, vertigo/dizziness and reporting on nystagmus and/or AVS/AIS. Two reviewers independently screened articles and extracted predefined parameters. The review was registered with PROSPERO (CRD42024623068).
Results: Forty studies (n = 11,731 patients) were included, with 2730 patients being classified as AVS. Prevalence of AVS (with/without nystagmus) amongst all acutely dizzy patients was 16.4% and 50.5%, respectively, in two studies. 49.4% of central AVS cases were classified as AIS. Whereas AIS presentation was rare in AICA strokes (9%), fractions reached 40% (PICA), 57% (SCA), and 62% (PCA) for other vascular territories. Data on underlying causes in noncentral AIS was limited, with dysautonomia, drug intoxication, and heart disease being most frequently identified.
Conclusions: With almost 50% of central AVS cases presenting as AIS, this emphasizes the importance of selecting bedside testing…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 11,731 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.